Literature DB >> 32862394

Autologous mesenchymal stem cells application in post-burn scars treatment: a preliminary study.

Peter Zahorec1, Nina Sarkozyova2, Nikola Ferancikova2, Peter Bukovcan2, Lubos Danisovic3, Martin Bohac4, Miroslav Tomas5, Jan Koller2.   

Abstract

Mesenchymal stem cells (MSCs) are multi-potent cells characterized by long term self-renewal and by potential for differentiation into cells of different mesenchymal tissue types such as fibroblasts, osteocytes, chondrocytes, and adipocytes. Their unique properties offer broad therapeutic potentials. Bone marrow has been used as the most common MSCs source, but it is gradually going to be replaced by adipose tissue which showed to contain more MSCs per unit than the bone marrow and clinical application of MSCs procured from the adipose tissue have been demonstrating at least similar results. Post-burn scars result frequently in severe both functional and aesthetic impairments in restitution and rehabilitation periods of the burn disease. Despite extensive research in the last decades, the exact mechanisms of scar formation remains unclear. The development of post-burn scars is influenced by multiple factors such as initial depth of the burn, methods of burn wound therapy, duration of the open wound until final wound closure, burn wound infection, genetic predisposition, and many others in both acute and rehabilitation periods. The aim of this study was to point out versatility of the implementation of this method with respect to different types of scars (atrophic scars, hypertrophic scars, keloids). Autologous adipose tissue derived MSCs were applied to post-burn scars in all 8 patients undergoing surgical scar reconstructions at the Department of Burns and Reconstructive Surgery of the University Hospital in Bratislava. The study was approved by Ethical Committee of Ruzinov Hospital. The procedures used for scar reconstructions included dermabrasion, scar excisions, contractures corrections and local plasties combined by lipografting of lipoaspirate containing parenchymal adipocytes and stromal vascular fraction including MSCs, or application of separated autologous MSCs isolated from lipoaspirates. Based on desired result one of these MSCs application methods was selected depending on characteristics of reconstructed scar and required volume of transferred fat. Isolation of MSCs following procurement was provided by the Central Tissue Bank cell culture laboratory which is one of the parts of the burn department. The average time of scars duration was 79 months, ranging from 6 to 216 months. The postburns scars were assessed clinically according to Vancouver Scar Scale (VSS) prior to surgery, including photo documentation, and re-evaluated after 6 months following MSCs application. As the results have shown, the average VSS score before treatment was 7.88 points ranging from 4 to 11 points. The average VSS 6 months after surgical procedure and MSCs application was 2.34 points ranging from 1 to 4 points. According to the results obtained, the favourable effect of adipose tissue derived autologous MSCs application on scar remodelling following surgical reconstruction of post-burn scars could be promising.

Entities:  

Keywords:  Lipografting; Mesenchymal stem cells (MSCs); Scar correction

Year:  2020        PMID: 32862394     DOI: 10.1007/s10561-020-09862-z

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  5 in total

Review 1.  Immunosuppression by mesenchymal stromal cells: from culture to clinic.

Authors:  Ben J Jones; Steven J McTaggart
Journal:  Exp Hematol       Date:  2008-06       Impact factor: 3.084

Review 2.  Stromal stem cells: marrow-derived osteogenic precursors.

Authors:  M Owen; A J Friedenstein
Journal:  Ciba Found Symp       Date:  1988

3.  Improvement of facial scar appearance and microcirculation by autologous lipofilling.

Authors:  N Pallua; A Baroncini; Z Alharbi; J P Stromps
Journal:  J Plast Reconstr Aesthet Surg       Date:  2014-05-20       Impact factor: 2.740

4.  Autologous fat graft as treatment of post short stature surgical correction scars.

Authors:  Luca Maione; Antonio Memeo; Leopoldo Pedretti; Fabio Verdoni; Andrea Lisa; Valeria Bandi; Silvia Giannasi; Valeriano Vinci; Andrea Mambretti; Marco Klinger
Journal:  Injury       Date:  2014-11-11       Impact factor: 2.586

5.  Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cells.

Authors:  Cestmir Altaner; Veronika Altanerova; Marina Cihova; Lubica Hunakova; Katarina Kaiserova; Andrej Klepanec; Ivan Vulev; Juraj Madaric
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

  5 in total
  3 in total

Review 1.  Adipose stromal vascular fraction: a promising treatment for severe burn injury.

Authors:  Khloud Fakiha
Journal:  Hum Cell       Date:  2022-07-30       Impact factor: 4.374

2.  Dihydroartemisinin Inhibits TGF-β-Induced Fibrosis in Human Tenon Fibroblasts via Inducing Autophagy.

Authors:  Xiaoyuan Wang; Wuqi Song; Fengmin Zhang; Renping Huang
Journal:  Drug Des Devel Ther       Date:  2021-03-03       Impact factor: 4.162

Review 3.  The Latest Developments in Immunomodulation of Mesenchymal Stem Cells in the Treatment of Intrauterine Adhesions, Both Allogeneic and Autologous.

Authors:  Jia-Ming Chen; Qiao-Yi Huang; Yun-Xia Zhao; Wei-Hong Chen; Shu Lin; Qi-Yang Shi
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.